REFERENCES
- Anderström C, Johansson SL, Schulz L. Primary adenocarcinoma of the urinary bladder, a clinicopatholo-gic and prognostic study. Cancer 1983; 52: 1273–80.
- Lamm DL. BCG in perspective: advances in the treatment of superficial bladder cancer. Eur Urol 1995; 27 (Suppl 1): 2–8.
- Sarosdy MF. Principles of intravesical chemotherapy and immunotherapy. Urol Clin North Am 1992; 19: 509–19.
- Zbar B, Bernstein ID, Rapp HJ. Suppression of tumor growth at the site of infection with living bacillus Calmette-Guerin. J Nat Cancer Inst 1971; 46: 831–9.
- Bassi P. Milani C, Meneghini A, Garbeglio A, Aragona F, Zattoni F, et al. Clinical value of pathologic changes after intravesical BCG therapy of superficial bladder cancer. Urology 1992; 40: 175–9.